CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Patel Chintu Co-CEO | Grant or award · Restricted Stock Units | +190,632 | 190,632 | ||
| 2026-03-02 | Patel Chintu Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +354,031 | 354,031 | ||
| 2026-03-02 | Patel Chirag K. President & Co-CEO | Grant or award · Restricted Stock Units | +190,632 | 190,632 | ||
| 2026-03-02 | Patel Chirag K. President & Co-CEO | Grant or award · Performance-Based Restricted Stock Units | +354,031 | 354,031 | ||
| 2026-03-02 | Shah Nikita Executive Vice President | Grant or award · Restricted Stock Units | +65,359 | 65,359 | ||
| 2026-03-02 | Shah Nikita Executive Vice President | Grant or award · Performance-Based Restricted Stock Units | +65,359 | 65,359 | ||
| 2026-03-02 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Restricted Stock Units | +72,622 | 72,622 | ||
| 2026-03-02 | Konidaris Tasos Executive Vice President & CFO | Grant or award · Performance-Based Restricted Stock Units | +72,622 | 72,622 | ||
| 2026-03-02 | Daly Jason B. EVP, Chief Legal Officer | Grant or award · Restricted Stock Units | +65,359 | 65,359 | ||
| 2026-03-02 | Daly Jason B. EVP, Chief Legal Officer | Grant or award · Performance-Based Restricted Stock Units | +65,359 | 65,359 | ||
| 2026-03-02 | BOYER ANDREW S Executive Vice President | Grant or award · Restricted Stock Units | +65,359 | 65,359 | ||
| 2026-03-02 | BOYER ANDREW S Executive Vice President | Grant or award · Performance-Based Restricted Stock Units | +65,359 | 65,359 | ||
| 2025-11-17 | Nark Ted C Director | Sale | −50,000 | $11.72 | $586K | 291,029 |
| 2025-11-12 | Shah Nikita Executive Vice President | Option exercise | +36,331 | $2.75 | $100K | 182,734 |
| 2025-11-12 | Shah Nikita Executive Vice President | Option exercise | +95,525 | $2.75 | $263K | 278,259 |
| 2025-11-12 | Shah Nikita Executive Vice President | Sale | −131,856 | $11.92 | $1.6M | 146,403 |
| 2025-11-12 | Shah Nikita Executive Vice President | Option exercise · Stock Option (Right to Buy) | −36,331 | 0 | ||
| 2025-11-12 | Shah Nikita Executive Vice President | Option exercise · Stock Option (Right to Buy) | −95,525 | 0 | ||
| 2025-08-27 | Kiely John Director | Sale | −32,000 | $9.23 | $295K | 225,433 |
| 2025-08-25 | Shah Nikita Executive Vice President | Sale | −6,340 | $9.50 | $60K | 146,403 |
Page 7 of 31 · 617 trades